JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB180649

Anti-Natriuretic peptides A antibody

Be the first to review this product! Submit a review

|

(21 Publications)

Rabbit Polyclonal proANP antibody. Suitable for WB and reacts with Mouse samples. Cited in 21 publications. Immunogen corresponding to Recombinant Fragment Protein within Human NPPA aa 1 to C-terminus.

View Alternative Names

ANP, PND, NPPA, Natriuretic peptides A, Atrial natriuretic factor prohormone, Atrial natriuretic peptide prohormone, Atriopeptigen, Cardiodilatin, preproCDD-ANF, proANF, preproANP, proANP, CDD

1 Images
Western blot - Anti-Natriuretic peptides A antibody (AB180649)
  • WB

Supplier Data

Western blot - Anti-Natriuretic peptides A antibody (AB180649)

Blocking buffer : 3% nonfat dry milk in TBST.

All lanes:

Western blot - Anti-Natriuretic peptides A antibody (ab180649) at 1/1000 dilution

Lane 1:

Mouse brain tissue lysate at 25 µg

Lane 2:

Mouse heart tissue lysate at 25 µg

Lane 3:

Mouse lung tissue lysate at 25 µg

Secondary

All lanes:

HRP Goat Anti-Rabbit IgG (H+L)

Predicted band size: 16 kDa

true

Exposure time: 60s

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

WB

applications

Immunogen

Recombinant Fragment Protein within Human NPPA aa 1 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P01160

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/2000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.3 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Natriuretic Peptides A also known as ANP ANF or NPPA are important cardiac hormones made by atrial myocytes in the heart. This peptide with a mass of around 28 amino acids plays an important role mechanically in modulating blood pressure and fluid balance. It achieves this by binding to receptors that activate cyclic GMP (cGMP) production leading to vasodilation. ANP expression is mainly found in cardiac muscle cells but also detected in other tissues under certain conditions.
Biological function summary

These peptides contribute to renal sodium excretion commonly known as natriuresis and also promote diuresis which increases urine volume. ANP functions as a singular hormone without forming part of a complex. Beyond its role in cardiovascular and renal systems ANP influences lipid metabolism and adipocyte functions which may have implications for metabolic health.

Pathways

ANP is engaged in the natriuretic peptide signaling pathway which is important for cardiovascular homeostasis. Within this pathway related proteins include B-type Natriuretic Peptide (BNP) and C-type Natriuretic Peptide (CNP) all of which share similar receptor interactions through cGMP. Additionally ANP impacts the renin-angiotensin system (RAS) a significant hormonal system regulating blood pressure and fluid balance by counteracting the actions of angiotensin II.

ANP is notably associated with heart failure where its levels can indicate disease severity and prognosis. Elevated ANP levels have also been linked to hypertension contributing to diagnostic evaluations alongside other biomarkers like BNP. Both heart failure and hypertension involve complex interactions between ANP and proteins such as angiotensin II within their pathophysiological frameworks.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Atrial natriuretic peptide. Hormone that plays a key role in mediating cardio-renal homeostasis, and is involved in vascular remodeling and regulating energy metabolism (PubMed : 15741263, PubMed : 16875975, PubMed : 18835931, PubMed : 21672517, PubMed : 22307324, PubMed : 2532366, PubMed : 2825692, PubMed : 7595132, PubMed : 7720651, PubMed : 8087923, PubMed : 8653797). Acts by specifically binding and stimulating NPR1 to produce cGMP, which in turn activates effector proteins, such as PRKG1, that drive various biological responses (PubMed : 1660465, PubMed : 1672777, PubMed : 21098034, PubMed : 2162527, PubMed : 22307324, PubMed : 25401746, PubMed : 2825692, PubMed : 7720651, PubMed : 8384600, PubMed : 9893117). Regulates vasodilation, natriuresis, diuresis and aldosterone synthesis and is therefore essential for regulating blood pressure, controlling the extracellular fluid volume and maintaining the fluid-electrolyte balance (PubMed : 2532366, PubMed : 2825692, PubMed : 7595132, PubMed : 7720651, PubMed : 8087923, PubMed : 8653797). Also involved in inhibiting cardiac remodeling and cardiac hypertrophy by inducing cardiomyocyte apoptosis and attenuating the growth of cardiomyocytes and fibroblasts (PubMed : 16875975). Plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus, and thus prevents pregnancy-induced hypertension (By similarity). In adipose tissue, acts in various cGMP- and PKG-dependent pathways to regulate lipid metabolism and energy homeostasis (PubMed : 15741263, PubMed : 18835931, PubMed : 21672517, PubMed : 22307324). This includes up-regulating lipid metabolism and mitochondrial oxygen utilization by activating the AMP-activated protein kinase (AMPK), and increasing energy expenditure by acting via MAPK11 to promote the UCP1-dependent thermogenesis of brown adipose tissue (PubMed : 15741263, PubMed : 18835931, PubMed : 21672517, PubMed : 22307324). Binds the clearance receptor NPR3 which removes the hormone from circulation (PubMed : 1672777).. Long-acting natriuretic peptide. May have a role in cardio-renal homeostasis through regulation of natriuresis, diuresis, vasodilation, and inhibiting aldosterone synthesis (PubMed : 2532366, PubMed : 2825692, PubMed : 7595132, PubMed : 7955907, PubMed : 8087923, PubMed : 8653797). In vitro, promotes the production of cGMP and induces vasodilation (PubMed : 2825692). May promote natriuresis, at least in part, by enhancing prostaglandin E2 synthesis resulting in the inhibition of renal Na+-K+-ATPase (PubMed : 7720651). However reports on the involvement of this peptide in mammal blood volume and blood pressure homeostasis are conflicting; according to a report, in vivo it is not sufficient to activate cGMP and does not inhibit collecting duct transport nor effect diuresis and natriuresis (By similarity). Appears to bind to specific receptors that are distinct from the receptors bound by atrial natriuretic peptide and vessel dilator (PubMed : 2162527, PubMed : 2825692). Possibly enhances protein excretion in urine by decreasing proximal tubular protein reabsorption (PubMed : 11145122).. Vessel dilator. May have a role in cardio-renal homeostasis through regulation of natriuresis, diuresis, and vasodilation (PubMed : 2532366, PubMed : 7595132, PubMed : 7955907, PubMed : 8087923, PubMed : 8653797). In vitro, promotes the production of cGMP and induces vasodilation (PubMed : 2825692). May promote natriuresis, at least in part, by enhancing prostaglandin E2 synthesis resulting in the inhibition of renal Na+-K+-ATPase (PubMed : 7595132, PubMed : 7720651). However reports on the involvement of this peptide in mammal blood volume and blood pressure homeostasis are conflicting; according to a report it is not sufficient to activate cGMP and does not inhibit collecting duct transport nor effect diuresis and natriuresis (PubMed : 7831500). Appears to bind to specific receptors that are distinct from the receptors bound by the atrial natriuretic and long-acting natriuretic peptides (PubMed : 2162527, PubMed : 2825692). Possibly functions in protein excretion in urine by maintaining the integrity of the proximal tubules and enhancing protein excretion by decreasing proximal tubular protein reabsorption (PubMed : 11145122).. Kaliuretic peptide. May have a role in cardio-renal homeostasis through regulation of diuresis and inhibiting aldosterone synthesis (PubMed : 2825692, PubMed : 7595132, PubMed : 8087923). In vitro, promotes the production of cGMP and induces vasodilation (PubMed : 2825692). May promote natriuresis, at least in part, by enhancing prostaglandin E2 synthesis resulting in the inhibition of renal Na+-K+-ATPase (PubMed : 7595132, PubMed : 7720651). May have a role in potassium excretion but not sodium excretion (natriuresis) (PubMed : 8087923). Possibly enhances protein excretion in urine by decreasing proximal tubular protein reabsorption (PubMed : 11145122).. Urodilatin. Hormone produced in the kidneys that appears to be important for maintaining cardio-renal homeostasis (PubMed : 8351194, PubMed : 8779891, PubMed : 8853410). Mediates vasodilation, natriuresis and diuresis primarily in the renal system, in order to maintain the extracellular fluid volume and control the fluid-electrolyte balance (PubMed : 2528951, PubMed : 8351194, PubMed : 8779891, PubMed : 8853410). Specifically binds and stimulates cGMP production by renal transmembrane receptors, likely NPR1 (PubMed : 8384600, PubMed : 9893117). Urodilatin not ANP, may be the natriuretic peptide responsible for the regulation of sodium and water homeostasis in the kidney (PubMed : 8384600, PubMed : 8779891).. Auriculin-D. May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis and in vitro, vasodilates renal artery strips.. Auriculin-B. May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis and in vitro, vasodilates renal artery strips.. Auriculin-A. May have a role in cardio-renal homeostasis through regulation of regulation of natriuresis and vasodilation. In vivo promotes natriuresis. In vitro, vasodilates intestinal smooth muscle but not smooth muscle strips.. Atriopeptin-2. May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis. In vitro, selectively vasodilates intestinal and vascular smooth muscle strips.. Atriopeptin-1. May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis. In vitro, selectively vasodilates intestinal smooth muscle but not vascular smooth muscle strips.
See full target information NPPA

Publications (21)

Recent publications for all applications. Explore the full list and refine your search

Cell communication and signaling : CCS 23:208 PubMed40307912

2025

Cytochrome P450 2E1 aggravates DXR-induced myocardial injury through imbalanced mitochondrial OPA1.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaxin Ma,Yaheng Wang,Huijiao Lv,Yu Lei,Feifei Guan,Wei Dong,He Wang,Lianfeng Zhang,Dan Lu

Cell death & disease 16:111 PubMed39971924

2025

17-beta estradiol prevents cardiac myocyte hypertrophy by regulating mitochondrial E3 ubiquitin ligase 1.

Applications

Unspecified application

Species

Unspecified reactive species

Ximena Calle,Valeria Garrido-Moreno,Brenda Becerra,Mayarling F Troncoso,Juan Francisco Silva-Agüero,Emanuel Guajardo-Correa,Leslye Venegas-Zamora,Erik Lopez-Gallardo,Felipe Muñoz-Córdova,Fernanda Fredericksen,Sebastian Aedo-Cares,Allan Peñaloza-Otárola,Angelica Ortega,Angel Raya,Vinicius Maracaja-Coutinho,Mario Chiong,Valentina Parra,Sergio Lavandero

FASEB bioAdvances 6:131-142 PubMed38706754

2024

Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction-associated steatotic liver disease.

Applications

Unspecified application

Species

Unspecified reactive species

Olufunto O Badmus,Alexandre A da Silva,Xuan Li,Lucy C Taylor,Jennifer R Greer,Andrew R Wasson,Karis E McGowan,Parth R Patel,David E Stec

Nature communications 14:959 PubMed36810848

2023

The KLF7/PFKL/ACADL axis modulates cardiac metabolic remodelling during cardiac hypertrophy in male mice.

Applications

Unspecified application

Species

Unspecified reactive species

Cao Wang,Shupei Qiao,Yufang Zhao,Hui Tian,Wei Yan,Xiaolu Hou,Ruiqi Wang,Bosong Zhang,Chaofan Yang,Fuxing Zhu,Yanwen Jiao,Jiaming Jin,Yue Chen,Weiming Tian

Frontiers in pharmacology 13:940574 PubMed36091816

2022

Rhein ameliorates transverse aortic constriction-induced cardiac hypertrophy regulating STAT3 and p38 MAPK signaling pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Run-Jing Li,Jia-Jia Xu,Zheng-Hao Zhang,Min-Wei Chen,Shi-Xiao Liu,Cui Yang,Yan-Ling Li,Ping Luo,Yi-Jiang Liu,Rong Tang,Zhong-Gui Shan

European journal of histochemistry : EJH 66: PubMed35726535

2022

MALAT1 regulates hypertrophy of cardiomyocytes by modulating the miR-181a/HMGB2 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Chen,Wenfeng Li,Dandan Zhang,Youlin Fu,Wenjin Yuan,Gang Luo,Fuwei Liu,Jun Luo

Frontiers in pharmacology 12:678886 PubMed34194329

2021

Loganin Inhibits Angiotensin II-Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Jia-Jia Xu,Run-Jing Li,Zheng-Hao Zhang,Cui Yang,Shi-Xiao Liu,Yan-Ling Li,Min-Wei Chen,Wei-Wei Wang,Gong-Ye Zhang,Gang Song,Zheng-Rong Huang

Frontiers in cardiovascular medicine 8:656093 PubMed33969020

2021

circSnx12 Is Involved in Ferroptosis During Heart Failure by Targeting miR-224-5p.

Applications

Unspecified application

Species

Unspecified reactive species

Haoyuan Zheng,Lin Shi,Changci Tong,Yunen Liu,Mingxiao Hou

Cell death & disease 12:216 PubMed33637715

2021

High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy.

Applications

Unspecified application

Species

Unspecified reactive species

Qing-Rui Wu,Dan-Lin Zheng,Pei-Ming Liu,Hui Yang,Lu-An Li,Su-Juan Kuang,Ying-Yu Lai,Fang Rao,Yu-Mei Xue,Ji-Jin Lin,Shuang-Xin Liu,Chun-Bo Chen,Chun-Yu Deng

Journal of cellular and molecular medicine 25:1100-1115 PubMed33295096

2020

MBNL1 regulates isoproterenol-induced myocardial remodelling in vitro and in vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Yao Xu,Chen Liang,Ying Luo,Tongcun Zhang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com